NDC11 71839014401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71839-0144-01 | 71839-0144 |
| 71839-0144-1 | 71839-0144 |
| 71839-144-01 | 71839-144 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dalbavancin | DALBAVANCIN | BE Pharmaceuticals Inc. | 6c188995-ab05-45c3-a3af-5b1bcd655fdc | 2026-06-12 | Warnings, Adverse reactions | 71839-144-01 71839-144 71839014401 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.